KAPLAN PHARMACOLOGY A PRACTICE TEST QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS
RATIONALES 2026 Q&A |STUDY GUIDE| INSTANT DOWNLOAD PDF
*
*
### Core Domains
*- Drug Classifications and High-Yield Medications*
*- Pharmacodynamics and Mechanisms of Action*
*- Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion)*
- Adverse Effects, Side Effects, and Toxicity
*- Drug Interactions and Contraindications*
*- Dosage Calculations and Medication Administration*
*- Patient Education and Nursing Considerations*
*- Regulatory, Legal, and Ethical Compliance in Medication Management*
*- Clinical Judgment and Decision-Making in Real-World Scenarios*
*- Safety Measures and Error Prevention*
*
### Introduction
This practice exam is designed to assess comprehensive mastery of pharmacology concepts essential for nursing and healthcare professionals.
The test evaluates critical knowledge including drug classifications, mechanisms of action, pharmacokinetic and pharmacodynamic processes,
adverse effects, drug interactions, dosage calculations, and clinical therapeutics. The assessment consists of 100 multiple-choice questions
incorporating both discrete items and scenario-based clinical situations that mirror real-world healthcare environments. Questions emphasize
applied professional knowledge, critical thinking, and decision-making skills necessary for safe medication administration and patient care. The
exam addresses regulatory compliance, ethical standards, patient education, and safety measures, preparing candidates for professional
certification exams and clinical practice where pharmacological competence directly impacts patient outcomes.
*
Section One: Questions 1–100
Question 1
A nurse is administering medication to a patient with renal impairment. Which pharmacokinetic process is most likely affected in this patient?
,A. Absorption
B. Distribution
C. Metabolism
D. Excretion
🟢 D. Excretion
🔴 RATIONALE: Excretion is the primary pharmacokinetic process affected in renal impairment since the kidneys are the main route for eliminating
many drugs and their metabolites. Reduced kidney function decreases drug clearance, leading to potential accumulation and toxicity.
Question 2
Which drug class is most appropriate for treating acute bronchospasm in a patient with asthma?
A. Beta-1 selective agonists
B. Beta-2 selective agonists
C. Alpha-1 agonists
D. Muscarinic antagonists
🟢 B. Beta-2 selective agonists
🔴 RATIONALE: Beta-2 selective agonists (such as albuterol) cause bronchodilation by stimulating beta-2 receptors in the bronchial smooth muscle,
making them the first-line treatment for acute bronchospasm in asthma.
Question 3
A patient is prescribed warfarin for anticoagulation. Which laboratory value must be monitored regularly to assess therapeutic effectiveness?
A. Platelet count
B. Prothrombin time (PT) and INR
C. Serum creatinine
D. Hemoglobin and hematocrit
🟢 B. Prothrombin time (PT) and INR
,🔴 RATIONALE: Warfarin affects the clotting cascade by inhibiting vitamin K-dependent clotting factors. PT and INR are the standard tests to
monitor warfarin's anticoagulant effect and ensure therapeutic levels (typically INR 2.0-3.0).
Question 4
Which of the following is a critical nursing consideration when administering IV potassium chloride?
A. Administer rapidly to achieve therapeutic levels
B. Never exceed 20 mEq/hour without continuous ECG monitoring
C. Give through a peripheral line only without dilution
D. Administer with a beta-blocker to prevent arrhythmias
🟢 B. Never exceed 20 mEq/hour without continuous ECG monitoring
🔴 RATIONALE: Rapid IV potassium administration can cause fatal cardiac arrhythmias. The maximum safe rate is typically 10-20 mEq/hour with
continuous ECG monitoring, and potassium must always be diluted in IV fluid.
Question 5
A patient taking lidocaine for ventricular arrhythmias develops which symptom that indicates toxicity?
A. Hypertension
B. Seizures and CNS depression
C. Tachycardia
D. Hyperglycemia
🟢 B. Seizures and CNS depression
🔴 RATIONALE: Lidocaine toxicity primarily affects the CNS, causing seizures, dizziness, confusion, and CNS depression. Cardiac toxicity can also
occur with severe overdose, but CNS symptoms are the earliest and most common indicators.
Question 6
Which medication is the priority antidote for opioid overdose?
, A. Flumazenil
B. Naloxone
C. Atropine
D. Acetylcysteine
🟢 B. Naloxone
🔴 RATIONALE: Naloxone is a competitive opioid receptor antagonist that rapidly reverses opioid-induced respiratory depression and is the
standard treatment for opioid overdose.
Question 7
A nurse is caring for a patient on digoxin. Which finding requires immediate intervention?
A. Serum digoxin level of 0.8 ng/mL
B. Heart rate of 52 beats/min
C. Serum potassium of 4.2 mEq/L
D. Mild fatigue
🟢 B. Heart rate of 52 beats/min
🔴 RATIONALE: Digoxin toxicity causes bradycardia. A heart rate below 60 beats/min in a patient on digoxin indicates potential toxicity and
requires immediate assessment and possible dose adjustment.
Question 8
Which drug class is contraindicated in patients with bilateral renal artery stenosis?
A. Beta-blockers
B. ACE inhibitors
C. Calcium channel blockers
D. Thiazide diuretics
🟢 B. ACE inhibitors
RATIONALES 2026 Q&A |STUDY GUIDE| INSTANT DOWNLOAD PDF
*
*
### Core Domains
*- Drug Classifications and High-Yield Medications*
*- Pharmacodynamics and Mechanisms of Action*
*- Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion)*
- Adverse Effects, Side Effects, and Toxicity
*- Drug Interactions and Contraindications*
*- Dosage Calculations and Medication Administration*
*- Patient Education and Nursing Considerations*
*- Regulatory, Legal, and Ethical Compliance in Medication Management*
*- Clinical Judgment and Decision-Making in Real-World Scenarios*
*- Safety Measures and Error Prevention*
*
### Introduction
This practice exam is designed to assess comprehensive mastery of pharmacology concepts essential for nursing and healthcare professionals.
The test evaluates critical knowledge including drug classifications, mechanisms of action, pharmacokinetic and pharmacodynamic processes,
adverse effects, drug interactions, dosage calculations, and clinical therapeutics. The assessment consists of 100 multiple-choice questions
incorporating both discrete items and scenario-based clinical situations that mirror real-world healthcare environments. Questions emphasize
applied professional knowledge, critical thinking, and decision-making skills necessary for safe medication administration and patient care. The
exam addresses regulatory compliance, ethical standards, patient education, and safety measures, preparing candidates for professional
certification exams and clinical practice where pharmacological competence directly impacts patient outcomes.
*
Section One: Questions 1–100
Question 1
A nurse is administering medication to a patient with renal impairment. Which pharmacokinetic process is most likely affected in this patient?
,A. Absorption
B. Distribution
C. Metabolism
D. Excretion
🟢 D. Excretion
🔴 RATIONALE: Excretion is the primary pharmacokinetic process affected in renal impairment since the kidneys are the main route for eliminating
many drugs and their metabolites. Reduced kidney function decreases drug clearance, leading to potential accumulation and toxicity.
Question 2
Which drug class is most appropriate for treating acute bronchospasm in a patient with asthma?
A. Beta-1 selective agonists
B. Beta-2 selective agonists
C. Alpha-1 agonists
D. Muscarinic antagonists
🟢 B. Beta-2 selective agonists
🔴 RATIONALE: Beta-2 selective agonists (such as albuterol) cause bronchodilation by stimulating beta-2 receptors in the bronchial smooth muscle,
making them the first-line treatment for acute bronchospasm in asthma.
Question 3
A patient is prescribed warfarin for anticoagulation. Which laboratory value must be monitored regularly to assess therapeutic effectiveness?
A. Platelet count
B. Prothrombin time (PT) and INR
C. Serum creatinine
D. Hemoglobin and hematocrit
🟢 B. Prothrombin time (PT) and INR
,🔴 RATIONALE: Warfarin affects the clotting cascade by inhibiting vitamin K-dependent clotting factors. PT and INR are the standard tests to
monitor warfarin's anticoagulant effect and ensure therapeutic levels (typically INR 2.0-3.0).
Question 4
Which of the following is a critical nursing consideration when administering IV potassium chloride?
A. Administer rapidly to achieve therapeutic levels
B. Never exceed 20 mEq/hour without continuous ECG monitoring
C. Give through a peripheral line only without dilution
D. Administer with a beta-blocker to prevent arrhythmias
🟢 B. Never exceed 20 mEq/hour without continuous ECG monitoring
🔴 RATIONALE: Rapid IV potassium administration can cause fatal cardiac arrhythmias. The maximum safe rate is typically 10-20 mEq/hour with
continuous ECG monitoring, and potassium must always be diluted in IV fluid.
Question 5
A patient taking lidocaine for ventricular arrhythmias develops which symptom that indicates toxicity?
A. Hypertension
B. Seizures and CNS depression
C. Tachycardia
D. Hyperglycemia
🟢 B. Seizures and CNS depression
🔴 RATIONALE: Lidocaine toxicity primarily affects the CNS, causing seizures, dizziness, confusion, and CNS depression. Cardiac toxicity can also
occur with severe overdose, but CNS symptoms are the earliest and most common indicators.
Question 6
Which medication is the priority antidote for opioid overdose?
, A. Flumazenil
B. Naloxone
C. Atropine
D. Acetylcysteine
🟢 B. Naloxone
🔴 RATIONALE: Naloxone is a competitive opioid receptor antagonist that rapidly reverses opioid-induced respiratory depression and is the
standard treatment for opioid overdose.
Question 7
A nurse is caring for a patient on digoxin. Which finding requires immediate intervention?
A. Serum digoxin level of 0.8 ng/mL
B. Heart rate of 52 beats/min
C. Serum potassium of 4.2 mEq/L
D. Mild fatigue
🟢 B. Heart rate of 52 beats/min
🔴 RATIONALE: Digoxin toxicity causes bradycardia. A heart rate below 60 beats/min in a patient on digoxin indicates potential toxicity and
requires immediate assessment and possible dose adjustment.
Question 8
Which drug class is contraindicated in patients with bilateral renal artery stenosis?
A. Beta-blockers
B. ACE inhibitors
C. Calcium channel blockers
D. Thiazide diuretics
🟢 B. ACE inhibitors
